O. Fusco
Impact in
- Immunology top 10%
- Galectins and Cancer Biology
- Toxin Mechanisms and Immunotoxins
-
- Peptidase Inhibition and Analysis
- Cancer Treatment and Pharmacology
Papers in
-
- Signaling Pathways in Disease 2
- Oncology 4
- Co-authors
- Stefano Iacobelli (6 shared papers)Clara Natoli (6 shared papers)Paola Matarrese (2 shared papers)Fu‐Tong Liu (2 shared papers)Nicola Tinari (3 shared papers)Walter Malorni (2 shared papers)Graziano Onder (1 shared paper)Roberto Bernabei (1 shared paper)
- Journals
- International Journal of Cancer (3 papers)Lung (1 paper)Advances in experimental medicine and biology (1 paper)Journal of Biological Chemistry (1 paper)APOPTOSIS (1 paper)
- Partner nations
- ItalyUnited StatesGermany
In The Last Decade
O. Fusco
12 papers receiving 443 citations
Peers
Comparison fields: 5 of 71
- Immunology 226
- Oncology 174
- Biological Psychiatry 10
- Cancer Research 50
- Molecular Biology 208
Countries citing papers authored by O. Fusco
This map shows the geographic impact of O. Fusco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O. Fusco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O. Fusco more than expected).
Fields of papers citing papers by O. Fusco
This network shows the impact of papers produced by O. Fusco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O. Fusco. The network helps show where O. Fusco may publish in the future.
Co-authors
The 25 scholars most cited alongside O. Fusco, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 206 | |
| 2 | 2005 | 68 | |
| 3 | 2009 | 47 | |
| 4 | 2001 | 35 | |
| 5 | 1998 | 31 | |
| 6 | 2004 | 18 | |
| 7 | 1997 | 12 | |
| 8 | 1999 | 12 | |
| 9 | 2000 | 12 | |
| 10 | 1999 | 10 | |
| 11 | 1999 | 6 | |
| 12 | A phase II study of neoadjuvant chemotherapy with cisplatin epirubicin and VP-16 for stage III unresectable non-small cell lung cancer. | 1998 | 1 |
About O. Fusco
O. Fusco is a scholar working on Molecular Biology, Oncology, Genetics, Immunology and Cancer Research, having authored 12 papers that have together received 458 indexed citations. Recurring topics across this work include Galectins and Cancer Biology (3 papers), Estrogen and related hormone effects (3 papers), Lung Cancer Diagnosis and Treatment (2 papers), Cancer, Lipids, and Metabolism (2 papers), Lung Cancer Treatments and Mutations (2 papers), Toxin Mechanisms and Immunotoxins (2 papers), Signaling Pathways in Disease (2 papers) and Inflammatory mediators and NSAID effects (2 papers). The work is most often cited by research in Immunology (226 citations), Oncology (174 citations), Biological Psychiatry (10 citations), Cancer Research (50 citations) and Molecular Biology (208 citations). O. Fusco has collaborated with scholars based in Italy, United States and Germany. Frequent co-authors include Stefano Iacobelli, Clara Natoli, Paola Matarrese, Fu‐Tong Liu, Nicola Tinari, Walter Malorni, Graziano Onder, Roberto Bernabei, Rosa Liperoti and Francisco Romeu Landi. Their work appears in journals such as International Journal of Cancer, Lung, Advances in experimental medicine and biology, Journal of Biological Chemistry and APOPTOSIS.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.